Navigation Links
Welch Foundation honors Orth as 'rising star' in chemistry
Date:2/3/2010

DALLAS Feb. 3, 2010 Dr. Kim Orth, associate professor of molecular biology at UT Southwestern Medical Center, was honored today with the 2010 Norman Hackerman Award in Chemical Research for pioneering work focusing on the mechanisms bacteria use to cause disease.

The Houston-based Welch Foundation, one of the nation's oldest and largest sources of private funding for basic research in chemistry, presents the award annually to honor up-and-coming scientists at Texas institutions. Recipients are recognized for expanding the frontiers of chemistry through their innovative research.

First bestowed in 2002, the award pays tribute to the late Norman Hackerman, a noted scientist and longtime chairman of the foundation's scientific advisory board. At a luncheon on the UT Southwestern campus, Dr. Orth received the $100,000 award and a crystal sculpture.

Dr. Orth has discovered new mechanisms by which invading bacteria hijack and deregulate a cell's signaling systems, cutting off the cell's ability to communicate with other immune-system cells that are needed to fight off disease. Dr. Orth's studies of these mechanisms have important implications in medicine, especially in understanding and potentially treating infectious diseases and immune-related diseases.

"Kim Orth is an original and creative biochemist and a tribute to our institution," said Dr. Daniel K. Podolsky, UT Southwestern president. "Her discovery of novel chemical modifications of proteins by bacteria that enter and kill cells is an important achievement. The groundbreaking advances made by her laboratory provide the foundation for a better understanding of many significant infectious diseases."

With the addition of Dr. Orth, four of the nine Hackerman Award recipients have been UT Southwestern faculty members. Other winners from the medical center are Dr. Xiaodong Wang, professor of biochemistry, in 2003; Dr. Zhijian "James" Chen, professor of molecular biology, in 2005; and Dr. Patrick Harran, former professor of biochemistry, in 2007.

"Kim Orth has already made important contributions to our understanding of how bacteria cause disease and what proteins control signaling in the cell," said Ernest H. Cockrell, chairman of The Welch Foundation. "Her creative, innovative and collaborative research tackles critical questions affecting humankind and lays a solid foundation for building new knowledge. We are pleased to salute her contributions as a young researcher and look forward to further advances from her lab."

Dr. Orth's studies also have uncovered previously unknown mechanisms human cells use to carry out normal functions. For example, she found that an infectious ocean-dwelling bacterium found in oysters and other shellfish kills its host's cells by causing them to burst, providing the invader with a nutrient-rich meal that can then be used to fuel proliferation. The invading pathogen overtakes the host's autophagy, or "self-eating" machinery, a process that is usually tightly controlled.

Understanding how this bacterium commandeers that process led to the discovery of an entirely new way that ATP a molecule that helps provide energy to our cells can alter other molecules. The modification process, which the bacterium exploits in its cell-smashing rampage, is so novel that Dr. Orth's research team created a new name for it: AMPylation.

"There is so much more to learn about the most fundamental mechanisms of life. Investing in basic research now pays dividends decades into the future," Dr. Orth said. "I am incredibly honored to be selected for this award, and I want The Welch Foundation to know how much I appreciate its support for basic science."

Dr. Orth studied psychology at Texas A&M University, but discovered a love for laboratory science after completing a molecular genetics course proctored by Dr. James Wild. She graduated with a degree in biochemistry, and then earned a master's degree from the University of California, Los Angeles.

Dr. Orth received her Ph.D. in biochemistry and molecular biology from UT Southwestern. She joined the UT Southwestern faculty in 2001 as a W.W. Caruth Jr. Scholar in Biomedical Research. In 2003 she was named a Beckman Young Investigator by the Arnold and Mabel Beckman Foundation, and in 2006 she was named a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease.


'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
2. David Welch, Friend, Advocate, Inspiration, Loses Courageous Battle to Brain Tumor
3. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
4. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
5. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
6. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
7. Welch Allyn Expands Network Services Contract With AT&T
8. Jack Welch to Headline the 8th Annual Lean Six Sigma Healthcare Summit
9. Welch Foundation gives $1.6 million for drug discovery research
10. The National Christian Foundation Offers to Match Gifts to Haiti
11. United Nations Foundation Applauds Bill and Melinda Gates for Their Commitment to Vaccinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... As President Trump challenges the status ... his administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, ... to make it through Congress. His discussion will focus on the current state ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... the way in unveiling cutting-edge birth defects research related to Zika virus during ... the world’s premier society for this important science. , The Teratology ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: